Paul E. Erdman

757 citations

15 papers · 379 · h-index 9

Impact in

Organic Chemistry top 10%
- Synthesis and biological activity
- Click Chemistry and Applications
- Synthesis and Characterization of Heterocyclic Compounds
- Quinazolinone synthesis and applications
Toxicology

Papers in

Oncology 8
- Cytokine Signaling Pathways and Interactions 5
- Peptidase Inhibition and Analysis 3
Organic Chemistry 7
- Quinazolinone synthesis and applications 3
- Synthesis and biological activity 3
- Click Chemistry and Applications 2

Co-authors: Moorthy S. S. Palanki (7 shared papers)Lynn J. Ransone (6 shared papers)Mark J. Suto (5 shared papers)Mark E. Goldman (4 shared papers)Philip B. Cox (2 shared papers)Anthony M. Manning (3 shared papers)Robert W. Sullivan (3 shared papers)Brydon L. Bennett (2 shared papers)
Journals: Bioorganic & Medicinal Chemistry Letters (6 papers)Journal of Medicinal Chemistry (2 papers)ACS Medicinal Chemistry Letters (1 paper)ACS Chemical Biology (1 paper)American Journal of Respiratory and Critical Care Medicine (1 paper)
Partner nations: United States Switzerland Japan

In The Last Decade

Paul E. Erdman

15 papers receiving 352 citations

Peers

Countries citing papers authored by Paul E. Erdman

Since Specialization

Citations

This map shows the geographic impact of Paul E. Erdman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul E. Erdman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul E. Erdman more than expected).

Fields of papers citing papers by Paul E. Erdman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul E. Erdman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul E. Erdman. The network helps show where Paul E. Erdman may publish in the future.

Co-authors

The 25 scholars most cited alongside Paul E. Erdman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Paul E. Erdman Line = papers co-authored together Paul E. Erdman links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work
1	Inhibitors of NF-κB and AP-1 Gene Expression: SAR Studies on the Pyrimidine Portion of 2-Chloro-4-trifluoromethylpyrimidine-5-[N-(3‘,5‘-bis(trifluoromethyl)phenyl)carboxamide] Journal of Medicinal Chemistry ·Moorthy S. S. Palanki, Paul E. Erdman, Leah M. Gayo‐Fung, Graziella I. Shevlin, Robert W. Sullivan, Mark E. Goldman, Lynn J. Ransone, Brydon L. Bennett, Anthony M. Manning, Mark J. Suto	2000	77
2	Discovery of Antibacterial Biotin Carboxylase Inhibitors by Virtual Screening and Fragment-Based Approaches ACS Chemical Biology ·Igor Mochalkin, J. Richard Miller, Lakshmi S. Narasimhan, Venkataraman Thanabal, Paul E. Erdman, Philip B. Cox, J. V. N. Vara Prasad, Sandra Lightle, Michael D. Huband, C. Kendall Stover	2009	77
3	Structure–Activity Relationship Studies of Ethyl 2-[(3-Methyl-2,5-dioxo(3-pyrrolinyl))amino]-4-(trifluoromethyl)pyrimidine-5-carboxylate: An Inhibitor of AP-1 and NF-κB Mediated Gene Expression Bioorganic & Medicinal Chemistry Letters ·Moorthy S. S. Palanki, Leah M. Gayo‐Fung, Graziella I. Shevlin, Paul E. Erdman, Mark Sato, Mark E. Goldman, Lynn J. Ransone, Cheryl Spooner	2002	41
4	2-Chloro-4-(trifluoromethyl)pyrimidine-5-N-(3‘,5‘-bis(trifluoromethyl)phenyl)- carboxamide: A Potent Inhibitor of NF-κB- and AP-1-Mediated Gene Expression Identified Using Solution-Phase Combinatorial Chemistry Journal of Medicinal Chemistry ·Robert W. Sullivan, Colin G. Bigam, Paul E. Erdman, Moorthy S. S. Palanki, David Walter Anderson, Mark E. Goldman, Lynn J. Ransone, Mark J. Suto	1998	38
5	The design and synthesis of novel orally active inhibitors of AP-1 and NF-κB mediated transcriptional activation. SAR of In vitro and In vivo studies Bioorganic & Medicinal Chemistry Letters ·Moorthy S. S. Palanki, Paul E. Erdman, Minghuan Ren, Mark J. Suto, Brydon L. Bennett, Anthony M. Manning, Lynn J. Ransone, Cheryl Spooner, Sonal J. Desai, Arnie Ow, Ryuichi Totsuka, Peter Tsao, Wataru Toriumi	2003	34
6	Design and Synthesis of Pyrrolidine-based Fragments That Sample Three-dimensional Molecular Space ACS Medicinal Chemistry Letters ·Philip Garner, Philip B. Cox, Upendra A. Rathnayake, Nicholas Holloran, Paul E. Erdman	2019	30
7	Novel inhibitors of AP-1 and NF-κB mediated gene expression: structure–activity relationship studies of ethyl 4-[(3-Methyl-2,5-dioxo(3-pyrrolinyl))amino]-2-(trifluoromethyl)pyrimidine-5-carboxylate Bioorganic & Medicinal Chemistry Letters ·Moorthy S. S. Palanki, Paul E. Erdman, Anthony M. Manning, Arnold Ow, Lynn J. Ransone, Cheryl Spooner, Carla M. Suto, Mark J. Suto	2000	28
8	Inhibition of Nuclear Factor-κB in T Cells Suppresses Lung Fibrosis American Journal of Respiratory and Critical Care Medicine ·Hajime Fujimoto, Corina N. D’Alessandro‐Gabazza, Moorthy S. S. Palanki, Paul E. Erdman, Takehiro Takagi, Esteban Cesar Gabazza, Nelson E. Bruno, Yutaka Yano, Tatsuya Hayashi, Shigenori Tamaki, Yasuhiro Sumida, Yukihiko Adachi, Koji Suzuki, Osamu Taguchi	2007	21
9	The novel protein homeostatic modulator BTX306 is active in myeloma and overcomes bortezomib and lenalidomide resistance Journal of Molecular Medicine ·Jianxuan Zou, Richard Julian Jones, H Wang, Isere Kuiatse, Fazal Shirazi, Elisabet Esteve Manasanch, Hans Chulhee Lee, Robert Sullivan, Leah M. Fung, Normand Richard, Paul E. Erdman, Eduardo Torres, David Hecht, Imelda Lam, Brooke McElwee, Aparajita H. Chourasia, Kyle Chan, Frank Mercurio, David Stirling, Robert Z. Orlowski	2020	9
10	Discovery of N-substituted 7-azaindoles as Pan-PIM kinases inhibitors – Lead optimization – Part III Bioorganic & Medicinal Chemistry Letters ·Claude Barberis, James Pribish, Elina Tserlin, Alexandre Gross, Mark Czekaj, Matthieu Barragué, Paul E. Erdman, Sachin Maniar, John Jiang, Luke Fire, Vinod F. Patel, Andrew T. Hebert, Mikhail N. Levit, Anlai Wang, Frank F. Sun, Shih-Min A. Huang	2018	8
11	Discovery of SARxxxx92, a pan-PIM kinase inhibitor, efficacious in a KG1 tumor model Bioorganic & Medicinal Chemistry Letters ·Claude Barberis, Paul E. Erdman, Mark Czekaj, Luke Fire, James Pribish, Elina Tserlin, Sachin Maniar, Joseph D. Batchelor, Jinyu Liu, Vinod F. Patel, Andrew T. Hebert, Mikhail N. Levit, Anlai Wang, Frank F. Sun, Shih-Min A. Huang	2020	7
12	Discovery of N-substituted 7-azaindoles as Pan-PIM kinase inhibitors – Lead series identification – Part II Bioorganic & Medicinal Chemistry Letters ·Claude Barberis, Neil D. Moorcroft, James Pribish, Elina Tserlin, Alexandre Gross, Mark Czekaj, Matthieu Barragué, Paul E. Erdman, Tahir N. Majid, Joseph D. Batchelor, Mikhail N. Levit, Andrew T. Hebert, Liduo Shen, Sandra Moreno-Mazza, Anlai Wang	2017	5
13	ChemInform Abstract: 2‐Chloro‐4‐(trifluoromethyl)pyrimidine‐5‐N‐(3′,5′‐bis (trifluoromethyl)phenyl)carboxamide: A Potent Inhibitor of NF‐ϰB‐ and AP‐1‐Mediated Gene Expression Identified Using Solution‐Phase Combinatorial Chemistry. ChemInform ·Robert W. Sullivan, Colin G. Bigam, Paul E. Erdman, Moorthy S. S. Palanki, David Walter Anderson, Mark E. Goldman, Lynn J. Ransone, Mark J. Suto	1998	2
14	Discovery of a PDE4B and PDE4D selective bifunctional degrader for management of chronic inflammatory disorders Journal of Translational Autoimmunity ·Arvind Shakya, Qiao Liu, Chon Lai, Sherry Pack Baker, Steven Greene, Paul E. Erdman, Athri D. Rathnayake, Angela Schoolmeesters, Connor M. Blair, Elka Kyurkchieva, Navin Rajapakse, Imelda Lam, Yuan Yan Sin, George S. Baillie, Shenlin Huang, Aparajita H. Chourasia, Leah M. Fung	2025	1
15	Outdoor Vector Lab The Physics Teacher ·Paul E. Erdman	2004	1

About Paul E. Erdman

Paul E. Erdman is a scholar working on Oncology, Organic Chemistry, Cancer Research, Pathology and Forensic Medicine and Molecular Biology, having authored 15 papers that have together received 379 indexed citations. Recurring topics across this work include Cytokine Signaling Pathways and Interactions (5 papers), NF-κB Signaling Pathways (4 papers), Cancer Mechanisms and Therapy (3 papers), Peptidase Inhibition and Analysis (3 papers), Quinazolinone synthesis and applications (3 papers), Synthesis and biological activity (3 papers), Click Chemistry and Applications (2 papers) and MXene and MAX Phase Materials (2 papers). The work is most often cited by research in Organic Chemistry (192 citations), Toxicology (15 citations), Cancer Research (60 citations), Pharmaceutical Science (23 citations) and Molecular Biology (169 citations). Paul E. Erdman has collaborated with scholars based in United States, Switzerland and Japan. Frequent co-authors include Moorthy S. S. Palanki, Lynn J. Ransone, Mark J. Suto, Mark E. Goldman, Philip B. Cox, Anthony M. Manning, Robert W. Sullivan, Brydon L. Bennett, Lakshmi S. Narasimhan and J. V. N. Vara Prasad. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Journal of Medicinal Chemistry, ACS Medicinal Chemistry Letters, ACS Chemical Biology and American Journal of Respiratory and Critical Care Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Paul E. Erdman

Impact in

Papers in i

In The Last Decade

Paul E. Erdman

Peers

Countries citing papers authored by Paul E. Erdman

Fields of papers citing papers by Paul E. Erdman

All Works

About Paul E. Erdman

Explore authors with similar magnitude of impact

Papers in